Translational_Unit

Part:BBa_K1202107

Designed by: Muhammed Taha Akcay   Group: iGEM13_ATOMS-Turkiye   (2013-09-24)
Revision as of 00:45, 5 October 2013 by Mustafa (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

TAT-E4-orf4: Cancer killing peptide

The general attitude to our parts is to designate alternative parts. For cancer killing mechanism, we searched through literature and found E4orf4 peptide. This derivative prospective cancer drug, like apoptin, induces apoptosis in cancer cells, selectively. Moreover, in literature and, of course iGEM, TAT-E4orf4 combination is completely novel.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 7
    Illegal NheI site found at 30
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 158
    Illegal NgoMIV site found at 167
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
Parameters
None